We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

195 hedge funds and large institutions have $51M invested in Editas Medicine in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 61 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

97% more call options, than puts

Call options by funds: $668K | Put options by funds: $339K

6% less funds holding

Funds holding: 207 → 195 (-12)

8.81% less ownership

Funds ownership: 61.84% → 53.03% (-8.8%)

21% less capital invested

Capital invested by funds: $64.8M → $51M (-$13.8M)

28% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 61

32% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 34

Holders
195
Holders Change
-12
Holders Change %
-5.8%
% of All Funds
2.61%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
23
Increased
44
Reduced
61
Closed
34
Calls
$668K
Puts
$339K
Net Calls
+$329K
Net Calls Change
+$321K

Top Buyers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
+$2.1M
2
Morgan Stanley
Morgan Stanley
New York
+$1.65M
3
Bank of America
Bank of America
North Carolina
+$1.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$946K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$822K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$3.62M
2
Goldman Sachs
Goldman Sachs
New York
-$1.79M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$1.65M
4
MAM
Monaco Asset Management
Monaco
-$1.36M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
Jones Financial Companies
126
Jones Financial Companies
Missouri
$2.65K +$908 +617 +41%
Nisa Investment Advisors
127
Nisa Investment Advisors
Missouri
$2.6K +$349 +237 +12%
GFM
128
GF Fund Management
China
$2.45K +$416 +283 +15%
TWD
129
True Wealth Design
Ohio
$1.84K +$1.83K +1,246 +363%
CCM
130
Coldstream Capital Management
Washington
$1.84K +$2.33K +1,582 New
SCM
131
Sterling Capital Management
North Carolina
$1.73K -$1.95K -1,326 -47%
S
132
SignatureFD
Georgia
$1.67K – – –
NA
133
NewEdge Advisors
Louisiana
$1.5K – – –
TLCM
134
Twin Lakes Capital Management
California
$1.45K – – –
EPIM
135
Evelyn Partners Investment Management
$1.39K -$1.1K -750 -38%
WSFS
136
Wilmington Savings Fund Society
Delaware
$1.16K – – –
SHIM
137
Stone House Investment Management
Pennsylvania
$1.16K +$1.47K +1,000 New
Optiver Holding
138
Optiver Holding
Netherlands
$922 +$640 +435 +121%
LSA
139
Leonteq Securities AG
Switzerland
$879 – – –
TCM
140
Tradewinds Capital Management
Washington
$812 +$1.03K +700 New
SPIA
141
Steward Partners Investment Advisory
New York
$609 – – –
AF
142
Allworth Financial
California
$605 +$78 +53 +16%
AWM
143
Ameliora Wealth Management
Switzerland
$580 – – –
HCM
144
Hollencrest Capital Management
California
$580 – – –
SC
145
SouthState Corp
Florida
$580 – – –
TWC
146
TD Waterhouse Canada
Ontario, Canada
$565 – – –
AWM
147
AllSquare Wealth Management
New York
$551 – – –
EWA
148
EverSource Wealth Advisors
Alabama
$517 -$137 -93 -17%
ICM
149
Islay Capital Management
Texas
$348 – – –
NFSG
150
Newbridge Financial Services Group
Florida
$348 – – –
4 5
6
7 8

EDIT Hedge Fund Activity: Q1 2025 in Review

195 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q1 2025, worth a combined $51M — down 21% from $64.8M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of EDIT and 23 opened new positions — a net loss of 11 holders — while 61 trimmed existing stakes and 44 added.

The largest buyer was UBS AM, adding an estimated $2.1M. The largest seller was Millennium Management, cutting an estimated $3.62M.

  • 195 institutional investors held Editas Medicine (EDIT) as of Q1 2025, down from 207 in Q4 2024.
  • Funds reported $51M of Editas Medicine stock for Q1 2025, down 21% quarter-over-quarter.
  • 23 funds opened new Editas Medicine positions in Q1 2025 and 34 closed out, a net change of -11 holders.
  • The largest Editas Medicine buyer in Q1 2025 was UBS AM, an estimated $2.1M added.
  • The largest Editas Medicine seller in Q1 2025 was Millennium Management, an estimated $3.62M sold.

Based on aggregated 13F filings for Q1 2025.